Jiang Zhong Pharmaceutical Co.,Ltd (SHA: 600750)

Jiang Zhong Pharmaceutical Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,145	1,333	1,371	1,046	1,100	927.3
Short-Term Investments	-	-	-	-	-	50.12
Trading Asset Securities	-	50.02	1,373	1,728	980.89	654.07
Cash & Short-Term Investments	1,145	1,383	2,744	2,774	2,081	1,631
Cash Growth	-59.19%	-49.60%	-1.07%	33.30%	27.54%	60.80%
Accounts Receivable	574.8	544.91	775.45	793.54	896.52	1,143
Other Receivables	35.3	15.91	43.26	48.05	10.98	18.7
Receivables	610.1	560.82	818.71	841.6	914.04	1,162
Inventory	406.71	406.17	386.9	377.99	246.74	242.5
Prepaid Expenses	-	-	-	3.88	4.29	-
Other Current Assets	67.4	47.2	104.64	67.24	29.28	25.94
Total Current Assets	2,229	2,397	4,054	4,064	3,275	3,062
Property, Plant & Equipment	1,569	1,597	1,520	1,220	1,022	1,063
Long-Term Investments	1,803	1,597	174.94	158.76	156.58	218.27
Goodwill	41.74	41.74	41.74	41.74	14.78	14.78
Other Intangible Assets	393.43	401.1	379.07	395.55	377.81	360
Long-Term Deferred Tax Assets	57.83	60.45	44.45	44.9	38.98	37.03
Long-Term Deferred Charges	4.22	4.66	2.32	2.77	0.59	0.88
Other Long-Term Assets	46.5	28.82	59.02	68.97	38.01	3.59
Total Assets	6,144	6,129	6,276	5,998	4,924	4,759
Accounts Payable	119.67	156.25	236.81	205.72	45.56	56.31
Accrued Expenses	842.67	783.79	813.14	692.73	312.14	488.2
Current Portion of Leases	1.02	1.25	1.99	1.7	-	-
Current Income Taxes Payable	50.76	48.09	19.77	12.63	21.59	22.45
Current Unearned Revenue	237.15	292.16	358.66	299.95	169.04	111.99
Other Current Liabilities	314.07	304.41	247.33	103.83	53.15	69.96
Total Current Liabilities	1,565	1,586	1,678	1,317	601.49	748.91
Long-Term Leases	1.07	1.05	1.18	2.79	-	-
Long-Term Unearned Revenue	84.75	48.94	67.85	73.04	50.58	58.08
Long-Term Deferred Tax Liabilities	16.54	17.5	21.59	22.72	20.21	27.84
Total Liabilities	1,668	1,653	1,768	1,415	672.27	834.84
Common Stock	629.13	629.36	629.58	630	630	525
Additional Paid-In Capital	426.68	424.9	427.35	407.82	435.36	435.36
Retained Earnings	2,842	2,794	2,878	3,008	2,812	2,600
Treasury Stock	-12.27	-16.42	-31.5	-43.28	-	-
Total Common Equity	3,886	3,832	3,904	4,003	3,877	3,561
Minority Interest	590.89	643.59	604.41	579.45	374.43	363.73
Shareholders' Equity	4,476	4,475	4,508	4,582	4,251	3,924
Total Liabilities & Equity	6,144	6,129	6,276	5,998	4,924	4,759
Total Debt	2.09	2.3	3.16	4.49	-	-
Net Cash (Debt)	1,143	1,381	2,741	2,769	2,081	1,631
Net Cash Growth	-59.19%	-49.63%	-1.02%	33.08%	27.54%	72.72%
Net Cash Per Share	1.80	2.18	4.35	4.38	3.29	2.60
Filing Date Shares Outstanding	632.8	628.08	625.4	623.7	630	630
Total Common Shares Outstanding	632.8	628.08	625.4	623.7	630	630
Working Capital	663.92	811.18	2,377	2,748	2,674	2,313
Book Value Per Share	6.14	6.10	6.24	6.42	6.15	5.65
Tangible Book Value	3,450	3,389	3,483	3,566	3,484	3,186
Tangible Book Value Per Share	5.45	5.40	5.57	5.72	5.53	5.06
Buildings	1,481	1,481	1,083	1,059	1,029	1,078
Machinery	1,090	1,014	879.7	796.66	729.06	638.86
Construction In Progress	50.11	70.9	445.67	190.77	2.33	-

Source: S&P Capital IQ. Standard template. Financial Sources.